about
Toward precision medicine in Parkinson's diseaseBrain-gut-microbiota axis in Parkinson's diseaseThe Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous SystemNRF2-regulation in brain health and disease: implication of cerebral inflammationThe gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.Gut feelings about smoking and coffee in Parkinson's disease.Exploring Braak's Hypothesis of Parkinson's Disease.Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.Peptidoglycan recognition protein genes and risk of Parkinson's disease.Gut microbiota are related to Parkinson's disease and clinical phenotype.Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseasesGut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.Sirtuin-3 Is Expressed by Enteric Neurons but It Does not Play a Major Role in Their Regulation of Oxidative Stress.Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.Restoration of intestinal function in an MPTP model of Parkinson's Disease.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus MonkeysThe role of inflammation in sporadic and familial Parkinson's disease.Characterization of biometal profiles in neurological disorders.Enteric glial cells: new players in Parkinson's disease?The enteric glia: identity and functions.The role of neuroinflammation in dementias.Inflammation in Parkinson's disease: role of glucocorticoids.Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.Recognition and treatment of autonomic disturbances in Parkinson's disease.The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.What a gastrointestinal biopsy can tell us about Parkinson's disease?How strong is the evidence that Parkinson's disease is a prion disorder?Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models.Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.Enteric GFAP expression and phosphorylation in Parkinson's disease.Interactions between the microbiota, immune and nervous systems in health and disease.Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
P2860
Q26764954-418E3BAA-F243-432E-8149-A7E94EAC00FFQ26784403-20FFF230-5B3B-46A7-83ED-2368E37703D9Q28072096-0AB7A0E9-CF08-4824-908A-EE92846B35CFQ28397785-B0DEDCCF-4924-47FF-BE01-2D905EF7936FQ33731341-1815CD92-2B65-48C6-9E63-5D396ADDE19FQ34195302-7130DEEA-4C2D-49F9-BC1A-54DD63280358Q34416404-19E8DE61-73BB-48AA-B084-F826F8771BFBQ34552244-5ADF5571-BD0C-4AAE-8E0D-CAECA327F0E5Q34674177-9D6CB347-F526-4E59-83B4-8005F5C845F8Q35170538-F760128C-5687-4DDC-9B4C-50EF3E1419A0Q35492461-0D816E3C-7F09-4D56-B32D-340C0A861A62Q35510197-728A1E20-D31E-42F4-BCAC-45A79248AFC2Q35604746-A859D8FE-9212-4D5E-B2BF-48E2367E964DQ35833353-DC9C3A8A-87DA-4012-9DAC-58BE8CFE8F22Q35858073-D456BCD8-449A-48CF-B9AA-DDDA61525A66Q36212145-58C6484B-A1D7-4F95-8DDB-A4BBE3B64697Q36477852-053FEF71-7451-44DA-85D3-6FB5A2742940Q36712406-963D6426-7CF9-40B5-B39A-F2A6BC76175CQ37002601-EAB2CAE8-69F2-453E-83B6-B797416EF218Q37137476-6BDC5615-BF1F-4B3B-894A-BA4BB786B241Q37516494-B18C11CB-BB43-42FB-B606-0733F8684153Q37579221-17EA0CF6-4E96-415E-B3AB-616FDF8F2642Q38105903-7B8BBB11-080E-49CE-B719-F6012EF5CA07Q38197094-877C0FC0-0476-4FFC-AF62-50261EB383C9Q38237626-B80DF9C4-DE65-4222-A7D2-E94DBE3B76C9Q38363866-8257E162-B17D-40D7-892A-8D031CC51BE5Q38365247-B104D101-FAE7-4261-AAC5-67EDD510A06AQ38425458-B6A11D95-D72E-412D-B7CF-CB55D5D81367Q38534940-73EF9D94-E2FE-4707-B43F-EE1FA5DABA6FQ38594855-07A299E5-3AC8-4A6E-92D9-053C8C74450FQ38607424-D3686598-0F1B-4E9D-A609-3B3F2EB94067Q38690133-A022F7B1-9695-413B-8483-24D85C8F8D03Q38749737-0AE5CDB0-57D9-4136-864A-472340956FC3Q38852629-6392F47A-9D66-476F-B67B-CC7336473814Q38950077-DD882516-FBA9-48BB-A56D-7BAFB1527C9EQ38962543-713572CD-2F16-4F11-B6F0-E3520BF2B96EQ39002538-FFC938F1-3F19-49FC-9695-D673D8ACE34BQ39090621-A7C845C4-1A73-459A-A3B7-D37DC5392B2FQ39965616-DE5B3978-0746-45BF-9089-7C0081A34B62Q39967268-4CD068AB-929A-41BE-827B-3661CD2A471A
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Colonic inflammation in Parkinson's disease.
@en
Colonic inflammation in Parkinson's disease.
@nl
type
label
Colonic inflammation in Parkinson's disease.
@en
Colonic inflammation in Parkinson's disease.
@nl
prefLabel
Colonic inflammation in Parkinson's disease.
@en
Colonic inflammation in Parkinson's disease.
@nl
P2093
P50
P1476
Colonic inflammation in Parkinson's disease.
@en
P2093
Bernard Lardeux
Emmanuel Coron
Hélène Pouclet
Jean-Michel Nguyen
Mandy Biraud
Michel Neunlist
Tiphaine Rouaud
P356
10.1016/J.NBD.2012.09.007
P577
2012-09-24T00:00:00Z